Jeong Park, PharmD, MS
She/Her
Clinical Professor
Pharmacy
As an integral member of the Michigan Medicine transplant team, Dr. Park participates in interdisciplinary care of kidney, liver and pancreas transplant patients in both inpatient and outpatient settings. Her transplant pharmacy team has developed and implemented various transplant practice guidelines and innovative pharmacy services. She is a founding member of the multidisciplinary Transplant Endocrine Clinic at Michigan Medicine.
Dr. Park has published original research and review articles relating to the field of transplantation, and has given presentations at local, national and international meetings. She has a strong commitment to education and training of students, residents, and new practitioners from multiple disciplines. In addition to providing didactic teaching and clinical rotations, she enjoys mentoring pharmacy learners on research and writing projects.
Projects:
CYP3A5 and tacrolimus
Research Area(s)
transplant
Publications
- Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients
- Use of complement binding assays to assess the efficacy of antibody mediated rejection therapy and prediction of graft survival in kidney transplantation
- Beyond Criteria and Definitions: Outcome of a Standardized Antibody-Mediated Rejection Protocol with a Diagnostic Schema Different from the Banff 2009 Criteria
Grants
- Principal investigator of: THE IRON ION-MYCOPHENOLATE MOFETIL CHALATION COMPLEX MINTERACTION: A TWO PAHSE PHARMACOKINETIC STUDY IN RENAL ALLOGRAFT RECIPIENTS AT THE UNIVERSITY OF MICHIGAN TRANSPLANT PROGRAM
- Principal investigator of: Efficacy and Safety of Thymoglobulin Induction in Living Unrelated Renal Transplantation
- Principal investigator of: Pharmacokinetics of Mycophenolate Mofetil Alone and in Combination with Valganciclovir in Renal and Heart Transplant Recipients